251 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
What's Next for Incyte? https://www.fool.com/investing/2018/04/16/whats-next-for-incyte.aspx?source=iedfolrf0000001 Apr 16, 2018 - With a key pipeline drug nixed, Incyte has a few more question marks on the horizon than it did before.
The Zacks Analyst Blog Highlights: Agios Pharmaceuticals, BioMarin Pharmaceutical, Vertex Pharmaceuticals and Incyte http://www.zacks.com/stock/news/299249/the-zacks-analyst-blog-highlights-agios-pharmaceuticals-biomarin-pharmaceutical-vertex-pharmaceuticals-and-incyte?cid=CS-ZC-FT-299249 Apr 16, 2018 - The Zacks Analyst Blog Highlights: Agios Pharmaceuticals, BioMarin Pharmaceutical, Vertex Pharmaceuticals and Incyte
What Happened With Incyte's IDO Inhibitor Flop https://www.fool.com/investing/2018/04/13/what-happened-with-incytes-ido-inhibitor-flop.aspx?source=iedfolrf0000001 Apr 13, 2018 - Investor confidence in epacadostat was through the roof, and the drug's phase 3 flop crushed the stock in a big way.
Pharma M&A Active This Week: 4 Potential Buyout Targets http://www.zacks.com/stock/news/299114/pharma-ma-active-this-week-4-potential-buyout-targets?cid=CS-ZC-FT-299114 Apr 13, 2018 - Novartis and Alexion announce respective acquisitions of AveXis and Wilson Therapeutics for a pipeline boost. We suggest four stocks as hot acquisition picks this year.
Why One Drug Flop Tanked Incyte's Stock https://www.fool.com/investing/2018/04/12/why-one-drug-flop-tanked-incytes-stock.aspx?source=iedfolrf0000001 Apr 12, 2018 - Biotech is risky business, and Incyte shareholders have not had a good week after a key drug flopped its phase 3.
Why GoPro, Incyte, and Wynn Resorts Jumped Today https://www.fool.com/investing/2018/04/12/why-gopro-incyte-and-wynn-resorts-jumped-today.aspx?source=iedfolrf0000001 Apr 12, 2018 - Find out which of these companies jumped on takeover chatter.
Is Beaten-Down Incyte Corporation Stock a Buy Now? https://www.fool.com/investing/2018/04/11/can-incyte-salvage-anything-from-its-latest-setbac.aspx?source=iedfolrf0000001 Apr 11, 2018 - A clinical-trial flop with epacadostat isn't the end of the world for Incyte.
Biotech Stock Roundup: Spectrum Up, Incyte Down, AveXis to Merge with Novartis http://www.zacks.com/stock/news/298800/biotech-stock-roundup-spectrum-up-incyte-down-avexis-to-merge-with-novartis?cid=CS-ZC-FT-298800 Apr 11, 2018 - The biotech sector was in the news last week as shares of Spectrum surged on positive data from a phase II study while Incyte plunged on the failure of melanoma study.
NewLink Shares Plunge After Incyte & Merck's Study Fails http://www.zacks.com/stock/news/298532/newlink-shares-plunge-after-incyte-mercks-study-fails?cid=CS-ZC-FT-298532 Apr 09, 2018 - Shares of NewLink Genetics Corp. (NLNT) plunged about 42.6% following the news of the failure of Incyte and Merck's phase III combination study for metastatic melanoma.
INCY: Gabelli & Co cuts to Hold http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180409094227 Apr 09, 2018 - Gabelli & Co issues rating change for INCY

Pages: 1...56789101112131415...26

<<<Page 10>